-
Epidemiological evidence presented at a recent Bethesda, MD-based National Cancer Institute (NCI) workshop could help end a longstanding debate on the question of induced abortion and risk of breast cancer.
-
Scientists recently conducted an international survey to explore womens willingness to use a contraceptive that induces amenorrhea.
-
Four years after its initial announcement to revive the Today contraceptive sponge, the company responsible for its rebirth finally has released the product in Canada and says it is pressing for Food and Drug (FDA) approval to market the device over the counter in the United States.
-
Without fanfare, the Bush administration has issued an important report to Congress on nondirective pregnancy options counseling in family planning clinics. Specifically, the report sought to assess the extent to which adoption information and referral is provided as part of nondirective counseling in publicly funded clinics.
-
McQueen CE. Melissa officinalis (lemon balm) to treat herpes labiablis. Altern Med Alert 2003;6(4):44-47.
-
-
Greenfield RH. PUFAs and atherosclerotic plaques. Altern Med Alert 2003;6(4):47-48.
-
O'Mathuna DP. Herb-drug interactions. Altern Med Alert 2003;6(4):37-44.
-
Greenfield RH. Homeopathic arnica and surgery. Altern Med Alert 2003;6(4):48.
-
FDA proposes labeling and manufacturing standards for all dietary supplements. Altern Med Alert 2003;6(4 Suppl):S1-S2.